New report highlights weak FDA oversight of foreign firms ma

As of 2022, 58% of makers of drugs bound for the US market were located overseas, the report notes.

Related Keywords

India , China , Mary Denigen Macauley , Government Accountability Office , Drug Administration , Representative Subcommittee , High Risk Series ,